NASDAQ$RGEN

Repligen Corp · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Repligen's first quarter was marked by substantial revenue growth, driven by COVID-related demand, base business strength, and acquisitions.

Repligen Corporation reported strong first-quarter results with an 88% increase in revenue to $142.8 million, driven by COVID-related demand, base business growth, and contributions from acquisitions. The company updated its full-year financial guidance to reflect expectations for operating margin expansion and organic revenue growth.

  • Revenue increased by 88% year-over-year, reaching $142.8 million, with organic growth of 69%.
  • COVID-related programs contributed 46 points, accounting for 53% of revenue growth.
  • The base business, excluding COVID-related contributions, grew by 31%.
  • GAAP operating margin was 25.5%, an increase of 980 bps, while adjusted operating margin was 32.0%, an increase of 790 bps.

Headline financials

Total Revenue

$143M

Previous: $76.1M+87.7%
EPS (adj)

$0.68

Previous: $0.32+112.5%
Gross Margin

58.2%

Previous: 58.0%+0.3%
Capital Expenditures

-$7.58M

Previous: -$4.13M-83.8%
Free Cash Flow

$21.9M

Previous: $5.69M+284.4%
Net Income

$29.5M

Previous: $9.82M+200.1%
Operating Income

$36.4M

Previous: $11.9M+205.6%
Gross Profit

$83.1M

Previous: $44.1M+88.4%
Cash & Equivalents

$711M

Previous: $530M+34.3%
Total Assets

$1.93B

Previous: $1.41B+37.0%
Stock-Based Comp

$6.54M

Previous: $4.17M+57.0%

Revenue & EPS history

Repligen · Revenue · Quarterly

$143M

Q1 2021+87.7%vs Q1 2020
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Repligen · $143M total across 2 segments · Q1 2021

  • Product Revenue
    $143M+87.7%
  • Royalty and Other
    $100K+233.3%

Forward guidance

Repligen updated its financial guidance for the fiscal year 2021, expecting total revenue to be in the range of $565-$590 million, reflecting overall revenue growth of 54%-61%. Organic growth is projected to be between 42%-49%.

Tailwinds

  • Total revenue is expected to be in the range of $565-$590 million, an increase from our previous guidance of $500-$525 million.
  • We expect overall revenue growth of 54%-61% and 52%-59% at constant currency.
  • Organic growth is expected to be in the range of 42%-49%, an increase from our previous guidance of 26%-33%.
  • Revenue from COVID-related programs is expected to be in the range of $140-$160 million, an increase from our previous guidance of $90-$100 million.
  • Fully diluted GAAP EPS is expected to be in the range of $1.67-$1.74, an increase from our previous guidance of $1.30-$1.38.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+2.6%

Avg return

Earnings day

+3.4%

Avg return

5 days after

+4.4%

Avg return

30 days after

59%

36 / 61 earnings

Positive

+22.1%

Q3 2018

Best reaction

-23.0%

Q3 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%-7.8%-2.7%
Q4 2025+1.4%-4.9%-15.5%
Q3 2025-5.9%-7.5%+6.3%
Q1 2025-2.9%-1.5%-14.8%
Q4 2024+7.9%+7.1%-7.1%
Q3 2024+7.9%-10.6%+11.8%
Q2 2024+21.3%+17.2%+9.2%
Q1 2024+1.3%+2.3%-9.2%
Q4 2023-3.2%-4.0%-0.9%
Q3 2023+15.1%+31.7%+37.7%
Q2 2023+1.1%+2.5%+5.2%
Q1 2023+6.4%+4.3%+8.8%
Q4 2022+3.2%-2.7%-10.0%
Q3 2022-6.0%-4.5%+3.1%
Q2 2022+13.1%+15.9%+0.6%
Q1 2022+7.8%+11.4%+19.3%
Q4 2021-1.8%-1.4%+4.0%
Q3 2021+7.2%+11.7%+5.5%
Q2 2021+14.2%+19.3%+32.4%
Q1 2021-6.4%-9.8%-15.6%
Q4 2020+0.3%+7.4%-11.1%
Q3 2020+8.1%+0.0%+0.8%
Q2 2020+8.7%+12.8%+8.2%
Q1 2020+6.7%+11.9%+5.0%
Q4 2019-10.1%-22.2%-18.7%
Q3 2019+9.9%+6.1%+15.1%
Q2 2019-4.0%-3.2%-1.7%
Q1 2019+2.5%-0.2%+11.5%
Q4 2018-0.2%+1.0%-0.2%
Q3 2018+22.1%+25.2%+19.3%
Q2 2018-1.0%+2.0%+14.2%
Q1 2018+5.1%+10.2%+14.9%
Q4 2017+9.2%+9.5%+6.2%
Q3 2017-7.1%-13.0%-4.9%
Q2 2017+1.3%+4.4%+6.1%
Q1 2017+5.2%+6.3%+11.7%
Q4 2016+6.3%+6.4%+13.6%
Q3 2016-4.1%-1.1%+10.0%
Q2 2016-0.6%-1.1%+3.9%
Q1 2016+2.1%
Q4 2015+2.4%
Q3 2015-23.0%
Q2 2015-0.2%
Q1 2015+16.9%
Q4 2014+14.9%
Q3 2014-6.6%
Q2 2014-3.6%
Q1 2014+5.0%
Q4 2013-8.8%
Q3 2013+8.8%
Q2 2013-0.1%
Q1 2013+2.9%
Q3 2010-5.0%
Q4 2012+5.8%
Q3 2012+10.2%
Q2 2012-0.4%
Q4 2010-1.5%
Q1 2012+0.9%
Q2 2011-0.1%
Q1 2011-0.9%
Q4 2011-0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro